Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04272008 · ClinicalTrials.gov registry record · Phase 1
The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol
A Phase 1 study, sponsored by TherapeuticsMD.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT04272008 is a Phase 1 study that has completed, run by TherapeuticsMD. The registered enrollment target is 21 participants.
The verdict
NCT04272008, a Phase 1 study, has completed, sponsored by TherapeuticsMD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
This study will evaluate the effect of Annovera and tampon co-usage on the pharmacokinetics (PK) of segesterone acetate (SA) and ethinyl estradiol (EE).
Interventions
- DRUG Segesterone Acetate and Ethinyl Estradiol
- OTHER Tampon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-03-06 |
| Est. Completion | 2021-06-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04272008
The ClinicalTrials.gov registry entry for NCT04272008 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TherapeuticsMD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Segesterone Acetate and Ethinyl Estradiol is the first listed.
NCT04272008 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04272008 about?
NCT04272008 is a clinical study titled "The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol". This study will evaluate the effect of Annovera and tampon co-usage on the pharmacokinetics (PK) of segesterone acetate (SA) and ethinyl estradiol (EE).
What is the current status of trial NCT04272008?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2020-03-06. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT04272008?
The interventions under investigation include: Segesterone Acetate and Ethinyl Estradiol (DRUG), Tampon (OTHER).
Who is sponsoring clinical trial NCT04272008?
This trial is sponsored by TherapeuticsMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.